Similar articles

• The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

  Shinmura K, Bolli R. Shinmura K, et al. Ann Intern Med. 2005 Oct 18;143(8):617; author reply 617-8. doi: 10.7326/0003-4819-143-8-200510180-00022. Ann Intern Med. 2005. PMID: 16230737 No abstract available.
• The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

  Kim JA, Choi YS, Yoon D, Cho KH. Kim JA, et al. Ann Intern Med. 2005 Oct 18;143(8):615-6; author reply 617-8. doi: 10.7326/0003-4819-143-8-200510180-00020. Ann Intern Med. 2005. PMID: 16230734 No abstract available.
• Summaries for patients. Risk for heart attacks with different NSAIDs.

  [No authors listed] [No authors listed] Ann Intern Med. 2005 Apr 5;142(7):I45. doi: 10.7326/0003-4819-142-7-200504050-00001. Ann Intern Med. 2005. PMID: 15809454 No abstract available.
• Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.

  Baigent C, Patrono C. Baigent C, et al. Arthritis Rheum. 2003 Jan;48(1):12-20. doi: 10.1002/art.10738. Arthritis Rheum. 2003. PMID: 12528099 Review. No abstract available.
• Arthritis. Should you be taking a COX-2 inhibitor?

  [No authors listed] [No authors listed] Harv Health Lett. 2001 Nov;27(1):1-3. Harv Health Lett. 2001. PMID: 11724695 Review. No abstract available.